The Kazakh authorities plan to launch a new biopharmaceutical plant in the Zhambyl region in September, where the QazVac domestic coronavirus vaccine will be produced, Kazakhstan’s Deputy Prime Minister Eraly Togjanov said at a cabinet meeting on Saturday, APA reports citing TASS.
"The work to put the biopharmaceutical plant into operation is in its final stages. The facility’s trial run proved successful on July 19. It has received a Good Manufacturing Practice certificate and a license for pharmaceutical activities. The plant will produce 600,000 doses of the QazVac vaccine monthly starting in September," he said.
The QazVac vaccine was created by experts from Kazakhstan’s Research Institute for Biosafety Problems.